World Tech News Turkmenistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech News Turkmenistan.

Press releases published on September 15, 2026

18 minutes ago

Templafy brings Document Agents to Claude, ChatGPT and Microsoft Copilot through MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy lleva Document Agents a Claude, ChatGPT y Microsoft Copilot mediante MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy intègre les Document Agents à Claude, ChatGPT et Microsoft Copilot via MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy מביאה סוכני מסמכים ל-Claude, ChatGPT ו-Microsoft Copilot דרך MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy macht Document Agents über MCP in Claude, ChatGPT und Microsoft Copilot verfügbar

Indeterminate GlobeNewswire

18 minutes ago

Templafy, MCP 통해 Claude·ChatGPT·Microsoft Copilot에 Document Agents 연동

Indeterminate GlobeNewswire

18 minutes ago

Templafy menghadirkan Document Agents ke Claude, ChatGPT, dan Microsoft Copilot melalui MCP

Indeterminate GlobeNewswire

18 minutes ago

テンプラファイ、MCPを通じてクロード、チャットGPT、マイクロソフト・コパイロットにドキュメント・エージェントを導入

Indeterminate GlobeNewswire

18 minutes ago

Templafy membawa Document Agents ke Claude, ChatGPT dan Microsoft Copilot melalui MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy Inclui Agentes de Documentos no Claude, ChatGPT e Microsoft Copilot com o MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy นำ Document Agents มาใช้งานบน Claude, ChatGPT และ Microsoft Copilot ผ่าน MCP

Indeterminate GlobeNewswire

18 minutes ago

Templafy 通过 MCP 将文档智能体接入 Claude、ChatGPT 和 Microsoft Copilot

Indeterminate GlobeNewswire

18 minutes ago

Templafy 透過 MCP 將文件代理帶到 Claude、ChatGPT 及 Microsoft Copilot

Indeterminate GlobeNewswire

28 minutes ago

PageUp Paige Named a 2026 Top HR Product of the Year by HR Executive

Indeterminate GlobeNewswire

31 minutes ago

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

Indeterminate GlobeNewswire

31 minutes ago

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Indeterminate GlobeNewswire

33 minutes ago

Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS

Indeterminate GlobeNewswire

33 minutes ago

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

33 minutes ago

Aeluma Executes Strategic Agreement with Sumitomo Chemical Advanced Technologies for Wafer Production for AI Datacom

Indeterminate GlobeNewswire

33 minutes ago

Satellos to Present at the 31st Annual Congress of the World Muscle Society

Indeterminate GlobeNewswire